Navigation Links
Cats' eye diseases genetically linked to diseases in humans
Date:3/4/2009

COLUMBIA, Mo. About one in 3,500 people are affected with retinitis pigmentosa (RP), a disease of the retina's visual cells that eventually leads to blindness. Now, a University of Missouri researcher has identified a genetic link between cats and humans for two different forms of RP. This discovery will help scientists develop gene-based therapies that will benefit both cats and humans.

"The same genetic mutations that cause retinal blindness in humans also cause retinal blindness in cats," said Kristina Narfstrom, the Ruth M. Kraeuchi-Missouri Professor in Veterinary Ophthalmology in the MU College of Veterinary Medicine. "Now, cats with these mutations can be used as important animal models to evaluate the efficiency of gene therapy. In addition, the eye is an ideal organ to use as we examine the potential of gene replacement intervention because it offers an accessible and confined environment."

Researchers examined the genetic mutations in two groups of cats; one with a congenital form of RP and another with a late-onset form and were able to identify the genes responsible for both forms of the disease in cats. In the study, researchers found that cats with the late-onset form of the disease have a mutation in the CEP290 gene, which is the same mutation found in humans with Joubert syndrome and Leber's congenital amaurosis. In both of these diseases, the genetic mutations result in changes in the function and structure of the photoreceptors. A photoreceptor is a nerve cell found in the eye's retina that is capable of phototransduction, or the process by which light is converted into electrical signals. The changes in the photoreceptors result in cell death, which lead to blindness.

"Cats are excellent models because they have relatively large eyes that are comparable to those of human babies. The retinal changes that occur and the progression to blindness in cats is similar to what happens in the human disease," Narfstrom said. "As a surgeon, I can use the same treatment methods and tools in cats that they use in humans."

Human autosomal recessive RP is among the most common cause of retinal degeneration and blindness, with no therapeutic intervention available. Initially it leads to night blindness, then loss of peripheral vision and, with progression, there is also a loss of central vision.

Like humans, Abyssinian cats with the CEP290 mutation have normal vision at birth but develop early changes in the interior of their eyes by the time they are approximately 2 years old. The cats with the congenital form of the disease are blind from birth with severe changes in the interior of their eyes after only a couple of months.


'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert  

Related biology news :

1. Choosing dry or wet food for cats makes little difference
2. The truth about cats and dogs
3. Dogs chase efficiently, but cats skulk counterintuitively
4. Big cats, wild pigs and short-eared dogs -- oh, my!
5. Clemson chemists discover new way antioxidants fight debilitating diseases
6. 60 second test could help early diagnosis of common brain diseases
7. U of MN researchers discover noninvasive diagnostic tool for brain diseases
8. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
9. Social habits of cells may hold key to fighting diseases
10. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
11. Zebrafish to shed light on human mitochondrial diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cats' eye diseases genetically linked to diseases in humans
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... Poway, California (PRWEB) , ... October 10, 2017 , ... ... afternoon speaking at his local San Diego Rotary Club. The event ... San Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology: